Nate N. Waldron

400 total citations
9 papers, 320 citations indexed

About

Nate N. Waldron is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Nate N. Waldron has authored 9 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Nate N. Waldron's work include Cancer Cells and Metastasis (6 papers), Immunotherapy and Immune Responses (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Nate N. Waldron is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Immunotherapy and Immune Responses (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Nate N. Waldron collaborates with scholars based in United States, China and Canada. Nate N. Waldron's co-authors include Daniel A. Vallera, Seunguk Oh, John R. Ohlfest, Amy P.N. Skubitz, Elizabeth Taras, Angela Panoskaltsis‐Mortari, Kristin L.M. Boylan, Zintis Inde, Melinda K. Hexum and Dan S. Kaufman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cancer Therapeutics and Gynecologic Oncology.

In The Last Decade

Nate N. Waldron

9 papers receiving 317 citations

Peers

Nate N. Waldron

ONCOL

MB

IMMUN

CR

RNMI

Thomas D. Southgate United Kingdom

Valentin Bruttel Germany

Christian Gieffers Germany

Jeanette Östling Sweden

Shruthi Prasad Germany

Nuray Gül Netherlands

Iris Mildenberger Germany

Laura A Strickland France

Yuxia Meng France

Denise Lally-Goss United States

Thomas D. Southgate United Kingdom

Nate N. Waldron

107 ×0.5

ONCOL

203 ×1.5

MB

71 ×0.6

IMMUN

39 ×1.0

CR

24 ×0.7

RNMI

Citations per year, relative to Nate N. Waldron Nate N. Waldron (= 1×) peers Thomas D. Southgate

Countries citing papers authored by Nate N. Waldron

Since Specialization

Citations

This map shows the geographic impact of Nate N. Waldron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nate N. Waldron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nate N. Waldron more than expected).

Fields of papers citing papers by Nate N. Waldron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nate N. Waldron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nate N. Waldron. The network helps show where Nate N. Waldron may publish in the future.

Co-authorship network of co-authors of Nate N. Waldron

This figure shows the co-authorship network connecting the top 25 collaborators of Nate N. Waldron. A scholar is included among the top collaborators of Nate N. Waldron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nate N. Waldron. Nate N. Waldron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Olin, Michael R., et al.. (2014). Victory and Defeat in the Induction of a Therapeutic Response through Vaccine Therapy for Human and Canine Brain Tumors: A Review of the State of the Art. Critical Reviews in Immunology. 34(5). 399–432. 12 indexed citations

2.

Moertel, Christopher L., Rebecca S. LaRue, Nate N. Waldron, et al.. (2014). CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy. Journal for ImmunoTherapy of Cancer. 2(1). 46–46. 56 indexed citations

3.

Skubitz, Amy P.N., Elizabeth Taras, Kristin L.M. Boylan, et al.. (2013). Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression. Gynecologic Oncology. 130(3). 579–587. 83 indexed citations

4.

Waldron, Nate N., et al.. (2013). A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma. Targeted Oncology. 9(3). 239–249. 35 indexed citations

5.

Waldron, Nate N. & Daniel A. Vallera. (2013). An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells. SHILAP Revista de lepidopterología. 2(1). 82–92. 3 indexed citations

6.

Ohlfest, John R., Jayanth Panyam, Suresh Kumar Swaminathan, et al.. (2012). Immunotoxin targeting CD133+ breast carcinoma cells. Drug Delivery and Translational Research. 3(2). 195–204. 33 indexed citations

7.

Swaminathan, Suresh Kumar, Lin Niu, Nate N. Waldron, et al.. (2012). Identification and characterization of a novel scFv recognizing human and mouse CD133. Drug Delivery and Translational Research. 3(2). 143–151. 13 indexed citations

8.

Waldron, Nate N., Seunguk Oh, & Daniel A. Vallera. (2012). Bispecific targeting of EGFR and uPAR in a mouse model of head and neck squamous cell carcinoma. Oral Oncology. 48(12). 1202–1207. 18 indexed citations

9.

Waldron, Nate N., Dan S. Kaufman, Seunguk Oh, et al.. (2011). Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck Cancer. Molecular Cancer Therapeutics. 10(10). 1829–1838. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact